apixaban (eliquis) Report issue

Small molecule Approved FDA Fast Track FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$1.0574 - $1.0575

VA Big4

$1.5075 - $1.5076

VA FSS

$1.5075 - $1.5076

NADAC

$7.9752 - $7.9842

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
apixaban 2.5 mg (TABLET) $1.0574 AUS PBS generic
  • Eliquis (60)
    		•  Bristol-Myers Squibb Australia Pty Ltd
    apixaban 2.5 mg (TABLET) $1.0575 AUS PBS generic
  • Eliquis (20)
    		•  Bristol-Myers Squibb Australia Pty Ltd
  • Eliquis (30)
    		•  Bristol-Myers Squibb Australia Pty Ltd
    apixaban 2.5 mg (TABLET) $1.5075 VA Big4
  • ELIQUIS (60)
    		•  Bristol-Myers Squibb Company
  • ELIQUIS (100)
    		•  Bristol-Myers Squibb Company
    apixaban 2.5 mg (TABLET) $1.5075 VA FSS
  • ELIQUIS (60)
    		•  Bristol-Myers Squibb Company
  • ELIQUIS (100)
    		•  Bristol-Myers Squibb Company
    apixaban 2.5 mg (TABLET) $7.9752 NADAC brand
  • ELIQUIS (1)
    		•  E.R. Squibb & Sons, L.L.C.
    apixaban 5 mg (TABLET) $1.0574 AUS PBS generic
  • Eliquis (60)
    		•  Bristol-Myers Squibb Australia Pty Ltd
    apixaban 5 mg (TABLET) $1.0575 AUS PBS generic
  • Eliquis (28)
    		•  Bristol-Myers Squibb Australia Pty Ltd
    apixaban 5 mg (TABLET) $1.5075 VA Big4
  • ELIQUIS (60)
    		•  Bristol-Myers Squibb Company
  • ELIQUIS (100)
    		•  Bristol-Myers Squibb Company
    apixaban 5 mg (TABLET) $1.5075 VA FSS
  • ELIQUIS (60)
    		•  Bristol-Myers Squibb Company
  • ELIQUIS (100)
    		•  Bristol-Myers Squibb Company
    apixaban 5 mg (TABLET) $1.5076 VA Big4
  • ELIQUIS (74)
    		•  Bristol-Myers Squibb Company
    apixaban 5 mg (TABLET) $1.5076 VA FSS
  • ELIQUIS (74)
    		•  Bristol-Myers Squibb Company
    apixaban 5 mg (TABLET) $7.9842 NADAC brand
  • ELIQUIS (1)
    		•  E.R. Squibb & Sons, L.L.C.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue